Philogen is a fully-integrated Swiss-Italian biotechnology company founded in 1996 with a mission to innovate the treatment of cancer and other serious conditions. The company has generated a strong proprietary pipeline of clinical-stage products.
Philochem, a subsidiary of the Philogen Group, and Bracco Imaging On Tuesday announced that they have entered into a license and collaboration agreement to...